{"id":"https://openalex.org/W7225189971","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1047","title":"1047 Alternative splicing-derived tumor-specific antigens as putative immunotherapeutic targets for glioblastoma","display_name":"1047 Alternative splicing-derived tumor-specific antigens as putative immunotherapeutic targets for glioblastoma","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225189971","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1047"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.1047","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1047","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1047","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1200.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A1200.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004229802","display_name":"Yufei Cui","orcid":"https://orcid.org/0000-0003-3014-813X","observed_orcids":["https://orcid.org/0000-0003-3014-813X"]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yufei Cui","raw_affiliation_strings":["Massachusetts Institute of Technology, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Institute of Technology, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074121271","display_name":"Aram Shajii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aram Shajii","raw_affiliation_strings":["Koch Institute for Cancer Research, Cambridge, MA, USA","Massachusetts Institute of Technology, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Koch Institute for Cancer Research, Cambridge, MA, USA","institution_ids":[]},{"raw_affiliation_string":"Massachusetts Institute of Technology, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075621139","display_name":"Michael Scott Regan","orcid":"https://orcid.org/0000-0001-5252-2829","observed_orcids":["https://orcid.org/0000-0001-5252-2829"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Scott Regan","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120395368","display_name":"Kaitlyn Bootz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaitlyn Bootz","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119665184","display_name":"Heidi M. Temple","orcid":"https://orcid.org/0009-0004-7437-7350","observed_orcids":["https://orcid.org/0009-0004-7437-7350"]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi M Temple","raw_affiliation_strings":["Massachusetts Institute of Technology, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Institute of Technology, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014002048","display_name":"Jennifer K. Gantchev","orcid":"https://orcid.org/0000-0001-5236-0671","observed_orcids":["https://orcid.org/0000-0001-5236-0671"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Gantchev","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160490466","display_name":"Dani Burgenske","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dani Burgenske","raw_affiliation_strings":["Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046979141","display_name":"Nathalie Y.R. Agar","orcid":"https://orcid.org/0000-0003-3149-3146","observed_orcids":["https://orcid.org/0000-0003-3149-3146"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathalie Agar","raw_affiliation_strings":["Brigham and Women\u2019s Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women\u2019s Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015247761","display_name":"Jann Nagina Sarkaria","orcid":"https://orcid.org/0000-0001-7489-4885","observed_orcids":["https://orcid.org/0000-0001-7489-4885"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jann Sarkaria","raw_affiliation_strings":["Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136997863","display_name":"Terry Burns","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terry Burns","raw_affiliation_strings":["Mayo Clinic, Rochester, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002079869","display_name":"Forest M. White","orcid":"https://orcid.org/0000-0002-1545-1651","observed_orcids":["https://orcid.org/0000-0002-1545-1651"]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Forest M White","raw_affiliation_strings":["Massachusetts Institute of Technology, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Institute of Technology, Cambridge, MA, USA","institution_ids":["https://openalex.org/I63966007"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1200","last_page":"A1200"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.3215000033378601,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.3215000033378601,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.3131999969482422,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.27880001068115234,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9800000190734863},{"id":"https://openalex.org/keywords/alternative-splicing","display_name":"alternative splicing","score":0.9869999885559082},{"id":"https://openalex.org/keywords/mhc-class-i-antigen-presentation","display_name":"MHC class I antigen presentation","score":0.8859999775886536},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6959999799728394},{"id":"https://openalex.org/keywords/immunopeptidomics","display_name":"immunopeptidomics","score":0.8690000176429749},{"id":"https://openalex.org/keywords/phosphoproteomics","display_name":"phosphoproteomics","score":0.7839999794960022},{"id":"https://openalex.org/keywords/tumor-specific-antigens","display_name":"tumor-specific antigens","score":0.5220000147819519},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.6069999933242798},{"id":"https://openalex.org/keywords/intron-retention","display_name":"intron retention","score":0.6660000085830688},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8349999785423279},{"id":"https://openalex.org/keywords/t-cell-response","display_name":"T cell response","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.8654999732971191},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5932999849319458},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5920000076293945},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5713000297546387},{"id":"https://openalex.org/C3019217517","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor associated antigen","level":4,"score":0.4722999930381775},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4090000092983246},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.3573000133037567},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31450000405311584},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30079999566078186},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.2734000086784363},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2513999938964844}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.1047","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1047","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1047","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1200.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.1047","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1047","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1047","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1200.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225189971.pdf","grobid_xml":"https://content.openalex.org/works/W7225189971.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2986654807","https://openalex.org/W3121770643","https://openalex.org/W4409152592","https://openalex.org/W4392882159","https://openalex.org/W4362524790","https://openalex.org/W4308378583","https://openalex.org/W4296329373","https://openalex.org/W7135015763","https://openalex.org/W3216643485","https://openalex.org/W7225201181"],"abstract_inverted_index":{"Background":[0],"Glioblastoma":[1],"(GBM)":[2],"remains":[3],"refractory":[4],"to":[5,18,49,60,66,332],"targeted":[6,152,213],"immunotherapy":[7,321],"because":[8],"its":[9],"tumor":[10,50,146,243,269,300,307],"antigens":[11,56,73],"are":[12],"heterogeneous,":[13],"variably":[14],"expressed,":[15],"and":[16,30,39,91,103,113,125,145,173,182,215,234,238,257,268,281,292,311],"susceptible":[17],"immune":[19,61],"escape.":[20],"Alternative":[21],"splicing":[22,44,54,288],"is":[23,31],"a":[24,189,326],"non-mutational":[25],"source":[26],"of":[27,176,217,272,329],"MHC-I":[28,79,133,295],"ligands":[29],"broadly":[32,293],"dysregulated":[33],"in":[34,232,241,275,312],"cancer.":[35],"In":[36,195,245],"GBM,":[37,197],"phosphoproteomic":[38],"transcriptional":[40],"profiling":[41],"revealed":[42,171],"that":[43,285],"programs":[45],"may":[46],"be":[47],"coupled":[48],"development,":[51],"making":[52],"resulting":[53],"derived":[55],"potentially":[57],"less":[58],"vulnerable":[59],"editing.":[62],"Here,":[63],"we":[64],"sought":[65],"identify":[67],"naturally":[68,290],"presented,":[69],"recurrent,":[70],"tumor-selective":[71],"splicing-derived":[72],"(SDAs)":[74],"as":[75],"translational":[76],"candidates":[77],"for":[78,192,339],"antigen-directed":[80],"immunotherapy.Methods":[81],"We":[82],"integrated":[83,279],"spatially":[84],"resolved":[85],"phosphoproteomics,":[86],"bulk":[87],"RNA-seq":[88],"alternative-splicing":[89],"analysis,":[90],"LC-MS/MS":[92],"immunopeptidomics":[93],"across":[94,221,252,259],"murine":[95,196],"GBM":[96,99,186,254,262,333],"models,":[97],"human":[98,246],"patient-derived":[100],"xenografts":[101],"(PDX),":[102],"primary":[104,261],"patient":[105],"tumors.":[106,263],"GBM-enriched":[107],"skipped":[108],"exons,":[109],"alternative":[110,287],"splice":[111,302],"sites,":[112],"retained":[114],"introns":[115],"were":[116,130,200,210,219,250],"translated":[117],"into":[118,317],"custom":[119],"databases":[120],"containing":[121],"tumor-enriched":[122],"sequence":[123],"fragments":[124],"flanking":[126],"residues.":[127],"Candidate":[128],"SDAs":[129,199,249,274,305],"identified":[131],"from":[132,299],"immunopeptidomes,":[134],"prioritized":[135,208],"by":[136,212],"population":[137],"coverage,":[138],"manual":[139],"spectral":[140],"validation,":[141],"MHC":[142],"binding":[143],"predictions,":[144],"enrichment,":[147],"then":[148],"confirmed":[149,266],"using":[150,166],"SureQuant":[151],"mass":[153],"spectrometry":[154],"against":[155],"normal":[156,222],"tissues":[157],"or":[158,319],"paired":[159],"PBMC":[160],"controls.":[161],"Murine":[162],"immunogenicity":[163],"was":[164],"tested":[165],"circular":[167],"mRNA":[168,226],"vaccination.Results":[169],"Phosphoproteomics":[170],"spatial":[172],"temporal":[174],"enrichment":[175],"RNA-metabolism":[177],"pathways,":[178],"spliceosomal":[179],"factors":[180],"activation,":[181],"SRPK-associated":[183],"signaling":[184],"during":[185],"progression,":[187],"providing":[188],"mechanistic":[190],"rationale":[191],"SDA":[193],"discovery.":[194],"159":[198],"identified,":[201],"including":[202],"predicted":[203],"H2-Kb/H2-Db":[204],"binders,":[205],"where":[206],"8":[207],"peptides":[209],"validated":[211],"MS,":[214],"4":[216],"which":[218],"GBM-restricted":[220],"tissue":[223],"panels.":[224],"Circular":[225],"vaccination":[227],"induced":[228],"antigen-specific":[229],"T-cell":[230],"responses":[231],"GL261":[233],"CT2A":[235,242],"tumor-bearing":[236],"mice":[237],"significantly":[239],"delay":[240],"growth.":[244],"analyses,":[247],"251":[248],"detected":[251],"10":[253],"PDX":[255],"lines":[256],"405":[258],"16":[260],"Targeted":[264],"validation":[265,282],"recurrent":[267],"specific":[270],"presentation":[271],"several":[273],"HLA-restricted":[276,309],"populations.Conclusions":[277],"This":[278],"discovery":[280],"workflow":[283],"demonstrates":[284],"GBM-associated":[286],"generates":[289],"presented":[291],"applicable":[294],"antigens,":[296],"many":[297],"arising":[298],"enriched":[301],"isoforms.":[303],"Validated":[304],"show":[306],"selectivity,":[308],"sharing,":[310],"vivo":[313],"immunogenicity,":[314],"supporting":[315],"translation":[316],"off-the-shelf":[318],"semi-personalized":[320],"targets.":[322],"Splicing-derived":[323],"antigen":[324],"offer":[325],"new":[327],"pool":[328],"targets":[330],"linked":[331],"progression":[334],"programs,":[335],"expanding":[336],"therapeutic":[337],"options":[338],"tumors":[340],"with":[341],"limited":[342],"actionable":[343],"neoantigens.":[344]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}